Robert H. Shoemaker

24.3k total citations · 7 hit papers
189 papers, 20.4k citations indexed

About

Robert H. Shoemaker is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Robert H. Shoemaker has authored 189 papers receiving a total of 20.4k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Molecular Biology, 73 papers in Oncology and 39 papers in Cancer Research. Recurrent topics in Robert H. Shoemaker's work include Cancer therapeutics and mechanisms (17 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Drug Transport and Resistance Mechanisms (15 papers). Robert H. Shoemaker is often cited by papers focused on Cancer therapeutics and mechanisms (17 papers), Cancer, Hypoxia, and Metabolism (16 papers) and Drug Transport and Resistance Mechanisms (15 papers). Robert H. Shoemaker collaborates with scholars based in United States, Germany and Italy. Robert H. Shoemaker's co-authors include Dominic A. Scudiero, Anne Monks, Michael R. Boyd, Kenneth D. Paull, Donald L. Fine, Michael C. Alley, Betty J. Abbott, Joseph G. Mayo, Philip Skehan and Miriam L. Hursey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Robert H. Shoemaker

186 papers receiving 19.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Feasibility of a High-Flux Anticancer Drug Screen Using a Diverse Panel of Cultured Human Tumor Cell Lines

1991 2.9k citations Anne Monks, Robert H. Shoemaker et al. profile →
Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

1988 2.8k citations Anne Monks, Robert H. Shoemaker et al. profile →
Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines.

1988 2.1k citations Robert H. Shoemaker, Anne Monks et al. profile →
The NCI60 human tumour cell line anticancer drug screen

2006 2.0k citations Robert H. Shoemaker profile →
Comparison of In Vitro Anticancer-Drug-Screening Data Generated With a Tetrazolium Assay Versus a Protein Assay Against a Diverse Panel of Human Tumor Cell Lines

1990 859 citations Robert H. Shoemaker, Anne Monks et al. profile →
Display and Analysis of Patterns of Differential Activity of Drugs Against Human Tumor Cell Lines: Development of Mean Graph and COMPARE Algorithm

1989 816 citations Robert H. Shoemaker, Anne Monks et al. profile →
New Soluble-Formazan Assay for HIV-1 Cytopathic Effects: Application to High-Flux Screening of Synthetic and Natural Products for AIDS-Antiviral Activity

1989 615 citations Robert H. Shoemaker et al. profile →

Peers

Countries citing papers authored by Robert H. Shoemaker

Since Specialization

Citations

This map shows the geographic impact of Robert H. Shoemaker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert H. Shoemaker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert H. Shoemaker more than expected).

Fields of papers citing papers by Robert H. Shoemaker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert H. Shoemaker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert H. Shoemaker. The network helps show where Robert H. Shoemaker may publish in the future.

Co-authorship network of co-authors of Robert H. Shoemaker

This figure shows the co-authorship network connecting the top 25 collaborators of Robert H. Shoemaker. A scholar is included among the top collaborators of Robert H. Shoemaker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert H. Shoemaker. Robert H. Shoemaker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The ribosome-inactivating proteins MAP30 and Momordin inhibit SARS-CoV-2 2023 ·PLoS ONE ·Norman R. Watts, Elif Eren, Ira Palmer, Paul L. Huang, Philip Lin Huang, Robert H. Shoemaker, Sylvia Lee‐Huang, Paul T. Wingfield	3
2	Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis—Inducing Genes S100A4 and MACC1 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Janice Smith, Pia Herrmann, Robert H. Shoemaker, Wolfgang Walther, Ulrike Stein	10
3	Combination of Wnt/β-Catenin Targets S100A4 and DKK1 Improves Prognosis of Human Colorectal Cancer 2021 ·Cancers ·Mathias Dahlmann, Anne Monks, Erik Harris, Dennis Kobelt, Marc Osterland, (unknown), Pia Herrmann, Wolfgang Kemmner, Susen Burock, Wolfgang Walther, Robert H. Shoemaker, Ulrike Stein	9
4	Translational Advances in Cancer Prevention Agent Development (TACPAD) Virtual Workshop on Immunomodulatory Agents: Report 2021 ·Journal of Cancer Prevention ·Altaf Mohammed, Roderick H. Dashwood, Sally E. Dickinson, Mary L. Disis, Elizabeth M. Jaffee, Bryon D. Johnson, Samir N. Khleif, Michaël Pollak, Jeffrey Schlom, Robert H. Shoemaker, Sasha E. Stanton, Georg T. Wondrak, Ming You, Hao Zhu, Mark Steven Miller	1
5	Pulmonary Aerosol Delivery of Let‐7b microRNA Confers a Striking Inhibitory Effect on Lung Carcinogenesis through Targeting the Tumor Immune Microenvironment 2021 ·Advanced Science ·Qi Zhang, Jing Pan, Donghai Xiong, Yian Wang, Mark Steven Miller, Shizuko Sei, Robert H. Shoemaker, Alberto Izzotti, Ming You	28
6	Improvement of RG1-VLP vaccine performance in BALB/c mice by substitution of alhydrogel with the next generation polyphosphazene adjuvant PCEP 2021 ·Human Vaccines & Immunotherapeutics ·Sarah Valencia, (unknown), Alexander Marin, (unknown), (unknown), (unknown), Chelsea Sanders, Simone Difilippantonio, Reinhard Kirnbauer, Richard B.S. Roden, Lígia A. Pinto, Robert H. Shoemaker, Alexander K. Andrianov, Jason D. Marshall	14
7	WRN helicase safeguards deprotected replication forks in BRCA2-mutated cancer cells 2021 ·Nature Communications ·Arindam Datta, Kajal Biswas, Joshua A. Sommers, (unknown), (unknown), Claudia M. Nicolae, Tanay Thakar, George‐Lucian Moldovan, Robert H. Shoemaker, Shyam K. Sharan, Robert M. Brosh	31
8	Optimization of RG1-VLP vaccine performance in mice with novel TLR4 agonists 2020 ·Vaccine ·(unknown), Erin Harberts, Sarah Valencia, (unknown), Chelsea Sanders, Akshay Jain, Nicholas R. Larson, C. Russell Middaugh, William D. Picking, Simone Difilippantonio, Reinhard Kirnbauer, Richard B.S. Roden, Lígia A. Pinto, Robert H. Shoemaker, Robert K. Ernst, Jason D. Marshall	20
9	Combination of Erlotinib and Naproxen Employing Pulsatile or Intermittent Dosing Profoundly Inhibits Urinary Bladder Cancers 2019 ·Cancer Prevention Research ·Altaf Mohammed, Mark Steven Miller, Ronald A. Lubet, Chen S. Suen, Shizuko Sei, Robert H. Shoemaker, M. Margaret Juliana, (unknown), Clinton J. Grubbs	8
10	Potentiation of Kras peptide cancer vaccine by avasimibe, a cholesterol modulator 2019 ·EBioMedicine ·Jing Pan, Qi Zhang, Katie Palen, Li Wang, (unknown), Bryon D. Johnson, Shizuko Sei, Robert H. Shoemaker, Ronald A. Lubet, Yian Wang, Ming You	49
11	Screening of Chemopreventive Agents in Animal Models: Results on Reproducibility, Agents of a Given Class, and Agents Tested During Tumor Progression 2018 ·Cancer Prevention Research ·Ronald A. Lubet, Vernon E. Steele, Robert H. Shoemaker, Clinton J. Grubbs	4
12	Werner Syndrome Helicase Has a Critical Role in DNA Damage Responses in the Absence of a Functional Fanconi Anemia Pathway 2013 ·Cancer Research ·Monika Aggarwal, Taraswi Banerjee, Joshua A. Sommers, (unknown), Pietro Pichierri, Robert H. Shoemaker, Robert M. Brosh	65
13	A Pharmacologic Inhibitor of the Protease Taspase1 Effectively Inhibits Breast and Brain Tumor Growth 2011 ·Cancer Research ·David Y. Chen, (unknown), Brian A. Van Tine, Adam C. Searleman, Todd D. Westergard, Han Liu, Ho-Chou Tu, Shugaku Takeda, Yiyu Dong, David Piwnica‐Worms, Kyoung Joon Oh, Stanley J. Korsmeyer, Ann Hermone, (unknown), Robert H. Shoemaker, Emily H. Cheng, James J. Hsieh	35
14	Differential Involvement of Vascular Endothelial Growth Factor in the Survival of Hypoxic Colon Cancer Cells 2008 ·Cancer Research ·Maura Calvani, Daniela Trisciuoglio, Cristina Bergamaschi, Robert H. Shoemaker, Giovanni Melillo	63
15	Nelfinavir, A Lead HIV Protease Inhibitor, Is a Broad-Spectrum, Anticancer Agent that Induces Endoplasmic Reticulum Stress, Autophagy, and Apoptosis In vitro and In vivo 2007 ·Clinical Cancer Research ·Joell J. Gills, Jaclyn LoPiccolo, Junji Tsurutani, Robert H. Shoemaker, Carolyn J.M. Best, Mones Abu‐Asab, (unknown), Noel A. Warfel, Erin R. Gardner, Matthew Danish, M. Christine Hollander, Shigeru Kawabata, Maria Tsokos, William D. Figg, Patricia S. Steeg, Phillip A. Dennis	264
16	Cell Type–Specific, Topoisomerase II–Dependent Inhibition of Hypoxia-Inducible Factor-1α Protein Accumulation by NSC 644221 2007 ·Clinical Cancer Research ·(unknown), John H. Cardellina, Andrew G. Stephen, Annamaria Rapisarda, Badarch Uranchimeg, Karen M. Hite, William A. Denny, Robert H. Shoemaker, Giovanni Melillo	45
17	SAR analysis of substituted purines as topoisomerase II inhibitors identifies ATPase inhibitors with nanomolar activity. 2006 ·Cancer Research ·Lars H. Jensen, Peter Bjødstrup Jensen, Robert H. Shoemaker, Maxwell Sehested	2
18	A sterol mesylate activator of CEBPα signaling induces monocytic differentiation in human leukemia cells in vitro and in vivo 2006 ·Cancer Research ·Erik Harris, Constance J. Glover, Joseph W. Adelsberger, Melinda G. Hollingshead, Ronald L. Felsted, Robert H. Shoemaker, Anne Monks	3
19	Echinomycin, a Small-Molecule Inhibitor of Hypoxia-Inducible Factor-1 DNA-Binding Activity 2005 ·Cancer Research ·Dehe Kong, Eun‐Jung Park, Andrew G. Stephen, Maura Calvani, John H. Cardellina, Anne Monks, Robert J. Fisher, Robert H. Shoemaker, Giovanni Melillo	431
20	Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines 1997 ·International Journal of Cancer ·Carolyn M. Laurençot, George L. Scheffer, Rik J. Scheper, Robert H. Shoemaker	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact